Abstract

BackgroundStudies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiographic parameters of systolic and diastolic dysfunction in such patients.MethodsIn this cross-sectional study, we evaluated patients with RA who were referred to our clinic from October 2017 to August 2018. After the exclusion of patients with concomitant CVD, all patients underwent transthoracic echocardiography and measurement of plasma autoantibodies. Moreover, possible confounders—including medications, CVD risk factors, Framingham risk score, disease activity score-28, duration of disease, simple disease activity index, and functional status—were assessed.ResultsWe studied 135 patients with RA (mean age = 52.3 years; 111 (82.2%) females). We had missing data rates of up to 8.9% for some characteristics. E velocity was inversely correlated with rheumatoid factor (P = 0.009). Furthermore, the plasma levels of anti-citrullinated protein and anti-modified citrullinated vimentin (anti-MCV) antibodies were negatively correlated with left ventricular ejection fraction (LVEF) (P = 0.019 and P<0.001, respectively). After an adjustment for possible confounders, the linear regression model demonstrated that the anti-MCV level and the patient’s age are significant predictors of LVEF. The receiver operating characteristic curve showed that anti-MCV antibody titer≥547.5 (IU/mL) signifies reduced LVEF (<50%) with a sensitivity of 85.7% and specificity of 93% (C-statistic = 0.843).ConclusionsOur findings showed a significant inverse correlation between anti-MCV antibody titer and LVEF. These results indicate that the application of anti-MCV is promising for the screening and early detection of cardiac systolic dysfunction. Future prospective studies will determine its role.

Highlights

  • Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs)

  • We evaluated parameters related to cardiac systolic and diastolic dysfunction, including the left ventricular ejection fraction (LVEF), pulmonary arterial pressure (PAP), E velocity, E/e’ ratio, tricuspid annular plane systolic excursion (TAPSE), isovolumic relaxation time (IVRT), and right ventricular systolic motion (RVSm)

  • We have investigated the correlation between autoantibodies and echocardiographic findings in patients with RA who were asymptomatic for CVDs

Read more

Summary

Introduction

Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). Introducing novel diagnostic biomarkers, imaging studies, and effective medications have diminished the debilities of the disorder in the face of its increased prevalence [1]. Most recent population-based studies have demonstrated that cardiovascular diseases (CVDs) are the leading cause of death among patients with RA [3, 4]. This can be attributed to the higher prevalence of conventional CVD risk factors among this population. Anti-citrullinated protein antibodies (ACPAs) can react with these neo-antigens and activate an inflammatory cascade, thereby causing tissue damage [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call